According the Centers for Disease Control and Prevention (CDC), about 4.5 million American adults are diagnosed with some form of liver disease. And worldwide statistics show that some form of liver disease accounts for over 2 million deaths per year.
However, coffee drinkers may have something going in their favor. That’s because not only is coffee one of the most commonly consumed beverages in the world, it is also a source of antioxidants that protect the liver.
Research shows that coffee decreases enzyme activity in the body that is connected to liver and heart conditions. In fact, coffee has been associated with improved outcomes with chronic liver disease, fibrosis, liver cancer, hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD). Additionally, coffee drinkers appear to have lower rates of breast cancer, prostate cancer, ovarian cancer, and pancreatic cancer.
Interestingly, even very little coffee yields big positive effects: just one cup daily showed a 15 percent reduction in risk of death from chronic liver disease, and four cups every day correlated with a 71 percent reduction in risk.
Heath RD, Brahmbhatt M, Tahan AC, Ibdah JA, Tahan V. Coffee: The magical bean for liver diseases. World J Hepatol. 2017 May 28;9(15):689-696.
Coffee has long been recognized as having hepatoprotective properties, however, the extent of any beneficial effect is still being elucidated. Coffee appears to reduce risk of hepatocellular carcinoma, reduce advancement of fibrotic disease in a variety of chronic liver diseases, and perhaps reduce ability of hepatitis C virus to replicate. This review aims to catalog the evidence for coffee as universally beneficial across a spectrum of chronic liver diseases, as well as spotlight opportunities for future investigation into coffee and liver disease.
[Choose from topics below to personalize articles fed to your home page]